Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 13.75
+1.50 (12.24%)
At close: Feb 27, 2026
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 38.03 million as of March 2, 2026. Its market cap has increased by 31.63% in one year.
Market Cap
38.03M
Enterprise Value
31.50M
Revenue
18.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.75
Market Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 38.03M, a decrease of -97.36%. That is a compound annual growth rate of -33.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 38.03M | 20.61% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 62.62M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |
| BriaCell Therapeutics | 37.78M |
| Defence Therapeutics | 35.00M |
| Resverlogix | 34.73M |
| Microbix Biosystems | 33.25M |